Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Next Previous
X
Search
Trial Profile

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin; Ticagrelor
  • Indications Myocardial infarction; Stroke; Thrombosis
  • Focus Therapeutic Use
  • Acronyms TALOS-AMI

    • Most Recent Events

    • 19 Sep 2022 Results of post hoc analysis assessing To evaluate the effect of the de-escalation strategy vs standard dual antiplatelet therapy (DAPT) with ticagrelor in stabilized AMI patients with HIR following percutaneouscoronary intervention (PCI) presented at the Transcatheter Cardiovascular Therapeutics 2022
    • 01 Mar 2022 Results published in the Annals of Internal Medicine
    • 19 Oct 2021 Primary endpoint (Cumulative incidence of Net adverse clinical event) has been met, as per results published in the Internet Document.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top